770
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes

, , , , , , & show all
Pages 239-246 | Received 12 Sep 2016, Accepted 25 Aug 2017, Published online: 16 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michael E Schatman & Hannah Shapiro. (2019) Damaging State Legislation Regarding Opioids: The Need To Scrutinize Sources Of Inaccurate Information Provided To Lawmakers. Journal of Pain Research 12, pages 3049-3053.
Read now
Adam J. Gordon$suffix/text()$suffix/text() & Elizabeth M. Oliva$suffix/text()$suffix/text(). (2018) Applying and advancing best practices in opioid use disorder and addiction treatment: Introduction to the special issue on implementation science and quality improvement scholarship. Substance Abuse 39:2, pages 125-128.
Read now

Articles from other publishers (18)

Shailina Keshwani, Steven M. Smith, Joshua Brown, Wei-Hsuan Lo-Ciganic, Seonkyeong Yang, Nicole E. Smolinski & Juan M. Hincapie-Castillo. (2023) Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting From 2006 to 2016. The Journal of Pain 24:11, pages 1994-2002.
Crossref
Mark OlfsonTimothy WaidmannMarissa KingVincent PanciniMichael Schoenbaum. (2023) Opioid Prescribing and Suicide Risk in the United States. American Journal of Psychiatry 180:6, pages 418-425.
Crossref
Mark Olfson, Timothy Waidmann, Marissa King, Vincent Pancini & Michael Schoenbaum. (2022) Population-Based Opioid Prescribing and Overdose Deaths in the USA: an Observational Study. Journal of General Internal Medicine 38:2, pages 390-398.
Crossref
Daniel M. Hartung, Jonah Geddes, Sara E. Hallvik, P. Todd Korthuis, Luke Middleton, Gillian Leichtling, Christi Hildebran & Hyunjee Kim. (2022) Evaluation of a Medicaid performance improvement project to reduce high-dose opioid prescriptions. BMC Health Services Research 22:1.
Crossref
Yuhua Bao, Hao Zhang, Daniel M. Hartung, Lisa R. Witkin & Judith A. Paice. (2022) Medicare Part D Coverage Restrictions and Patient Cost-Sharing for Opioids Commonly Used for Cancer Pain, 2015-2021. JCO Oncology Practice 18:10, pages e1574-e1586.
Crossref
Amy E. Seitz, Karen A. Janiszewski, Gery P. GuyJrJr, Ryan T. Tapscott, Emily B. Einstein, Tamra E. Meyer, Jessica Tierney, Judy Staffa, Christopher M. Jones & Wilson M. Compton. (2022) Evaluating opioid analgesic prescribing limits: A narrative review. Pharmacoepidemiology and Drug Safety 31:6, pages 605-613.
Crossref
Neus Carrilero, Toni Mora & Anna García-Altés. (2022) The impact of an easy access drug supply management policy law on the consumption and abuse of opioids in Catalonia: A population-based study. International Journal of Drug Policy 101, pages 103562.
Crossref
Jean Deschamps, James Gilbertson, Sebastian Straube, Kathryn Dong, Frank P. MacMaster, Christina Korownyk, Lori Montgomery, Ryan Mahaffey, James Downar, Hance Clarke, John Muscedere, Katherine Rittenbach, Robin Featherstone, Meghan Sebastianski, Ben Vandermeer, Deborah Lynam, Ryan Magnussen, Sean M. Bagshaw & Oleksa G. Rewa. (2021) Association between supportive interventions and healthcare utilization and outcomes in patients on long-term prescribed opioid therapy presenting to acute healthcare settings: a systematic review and meta-analysis. BMC Emergency Medicine 21:1.
Crossref
Jennifer S. Gewandter, Shannon M. Smith, Robert H. Dworkin, Dennis C. Turk, Tong J. Gan, Ian Gilron, Sharon Hertz, Nathaniel P. Katz, John D. Markman, Srinivasa N. Raja, Michael C. Rowbotham, Brett R. Stacey, Eric C. Strain, Denham S. Ward, John T. Farrar, Kurt Kroenke, James P. Rathmell, Richard Rauck, Colville Brown, Penney Cowan, Robert R. Edwards, James C. Eisenach, McKenzie Ferguson, Roy Freeman, Roy Gray, Kathryn Giblin, Hanna Grol-Prokopczyk, Jennifer Haythornthwaite, Robert N. Jamison, Marc Martel, Ewan McNicol, Michael L. Oshinsky, Friedhelm Sandbrink, Joachim Scholz, Richard Scranton, Lee S. Simon, Deborah Steiner, Kenneth Verburg, Ajay D. Wasan & Kerry Wentworth. (2021) Research approaches for evaluating opioid sparing in clinical trials of acute and chronic pain treatments: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations. Pain 162:11, pages 2669-2681.
Crossref
Adeniyi T TogunPinar Karaca-MandicRebecca WurtzMolly JeffreyTimothy Beebe. (2021) Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices. Journal of Managed Care & Specialty Pharmacy 27:10, pages 1352-1364.
Crossref
Shane R. Mueller, Jason M. Glanz, Anh P. Nguyen, Melanie Stowell, Stephen Koester, Deborah J. Rinehart & Ingrid A. Binswanger. (2021) Restrictive opioid prescribing policies and evolving risk environments: A qualitative study of the perspectives of patients who experienced an accidental opioid overdose. International Journal of Drug Policy 92, pages 103077.
Crossref
Yu Wang, Matthew PerriIIIIII, Henry Young, Amanda Abraham & Jayani Jayawardhana. (2021) Impact of drug utilization management policy on prescription opioid use in Georgia Medicaid. Journal of Pharmaceutical Health Services Research 12:2, pages 188-193.
Crossref
Jeanne M. Sears, John R. Haight, Deborah Fulton‐Kehoe, Thomas M. Wickizer, Jaymie Mai & Gary M. Franklin. (2020) Changes in early high‐risk opioid prescribing practices after policy interventions in Washington State. Health Services Research 56:1, pages 49-60.
Crossref
Richard J. Bodnar. (2020) Endogenous Opiates and Behavior: 2018. Peptides 132, pages 170348.
Crossref
Sanae El Ibrahimi, Sara Hallvik, Kirbee Johnston, Gillian Leichtling, Esther Choo & Daniel M. Hartung. (2020) A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data. Pharmacoepidemiology and Drug Safety 29:9, pages 1168-1174.
Crossref
Bahareh Ansari, Katherine M. Tote, Eli S. Rosenberg & Erika G. Martin. (2020) A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018. Public Health Reports 135:1_suppl, pages 100S-127S.
Crossref
AMANDA I. MAURI, TARLISE N. TOWNSEND & REBECCA L. HAFFAJEE. (2019) The Association of State Opioid Misuse Prevention Policies With Patient‐ and Provider‐Related Outcomes: A Scoping Review. The Milbank Quarterly 98:1, pages 57-105.
Crossref
Richard A. Deyo, Sara E. Hallvik, Christi Hildebran, Miguel Marino, Rachel Springer, Jessica M. Irvine, Nicole O'Kane, Joshua Van Otterloo, Dagan A. Wright, Gillian Leichtling, Lisa M. Millet, Jody Carson, Wayne Wakeland & Dennis McCarty. (2018) Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers. The Journal of Pain 19:2, pages 166-177.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.